Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSATargeted Therapy in Patients with Suspected MRSA Pneumonia

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 4, 2017, Pages

  Baby, Nidhu ^a,b   Faust, Andrew C ^a   Smith, Terri ^a   Sheperd, Lyndsay A ^a   Knoll, Laura ^a   Goodmanb, Edward L ^a,b  

^a PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Antimicrobial stewardship; Methicillin resistant staphylococcus aureus; Pneumonia; Staphylococcus aureus; Vancomycin

Indexed keywords

LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HEALTH CARE PLANNING; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PHARMACIST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; DRUG EFFECTS; GENETICS; MICROBIOLOGY; MIDDLE AGED; NOSE; PNEUMONIA, STAPHYLOCOCCAL; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NOSE; PNEUMONIA, STAPHYLOCOCCAL; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TIME FACTORS; VANCOMYCIN;

EID: 85016576651     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02432-16     Document Type: Article

References (19)

1. Self WH, Wunderink RG, Williams DJ, Zhu Y, Anderson EJ, Balk RA, Fakhran SS, Chappell JD, Casimir G, Courtney DM, Trabue C, Waterer GW, Bramley A, Magill S, Jain S, Edwards KM, Grijalva CG. 2016. Staphylococcus aureus community-Acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis 63:300 -309. https://doi.org/10.1093/cid/ciw300.
2. Jones BE, Jones MM, Huttner B, Stoddard G, Brown KA, Stevens VW, Greene T, Sauer B, Madaras-Kelly K, Rubin M, Goetz MB, Samore M. 2015. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010. Clin Infect Dis 61:1403-1410. https://doi.org/10.1093/cid/civ629.
3. Lewis SS, Walker VJ, Lee MS, Chen L, Moehring RW, Cox CE, Sexton DJ, Anderson DJ. 2014. Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals. Infect Control Hosp Epidemiol 35:1452-1457. https://doi.org/10.1086/678594.
4. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JH, Carratala J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Robert JA, Waterer GM, Cruse P, Knight SL, Brozek JL. 2016. Management of adults with hospital-Acquired and ventilator-Associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:e61- e111. https://doi.org/10.1093/cid/ciw353.
5. American Thoracic Society. 2005. Infectious Diseases Society of America. Guidelines for the management of adults with hospital-Acquired, ventilator-Associated, and healthcare-Associated pneumonia. Am J Respir Crit Care Med 171:388-416.
6. Liu C, Bayer A, Cosgrove SE, Daum RB, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18-e55. https://doi.org/10.1093/cid/ciq015.
7. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L. 2015. Communityacquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:415-427. https://doi.org/10.1056/NEJMoa1500245.
8. Hill RL, Duckworth GJ, Casewell MW. 1988. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 22:377-384. https://doi.org/10.1093/jac/22.3.377.
9. French GL. 2009. Methods for screening for methicillin-resistant Staphylococcus aureus carriage. Clin Microbiol Infect 15(Suppl):S10 -S16.
10. Tilahun B, Faust AC, McCorstin P, Ortegon A. 2015. Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus. Am J Crit Care 24:8-12. https://doi.org/10.4037/ajcc2015102.
11. Langsjoen J, Brady C, Obenauf E, Kellie S. 2014. Nasal screening is useful in excluding methicillin-resistant Staphylococcus aureus in ventilatorassociated pneumonia. Am J Infect Control 42:1014 -1015. https://doi.org/10.1016/j.ajic.2014.05.026.
12. Dangerfield B, Chung A, Webb B, Seville MT. 2014. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother 58:859 - 864. https://doi.org/10.1128/AAC.01805-13.
13. Johnson JA, Wright ME, Sheperd LA, Musher DM, Dang BN. 2015. Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: A potential use in guiding antibiotic therapy for pneumonia. Perm J 19:34 -36.
14. Meyer E, Schwab F, Gastmeier P. 2010. Nosocomial methicillin resistant Staphylococcus aureus pneumonia-epidemiology and trends based on data of a network of 586 German ICUs (2005-2009). Eur J Med Res 15:514 -524. https://doi.org/10.1186/2047-783X-15-12-514.
15. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GEN, Albrecht V, Limbago B, Talan DA. 2012. Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-Acquired pneumonia. Clin Infect Dis 54:1126 -1133. https://doi.org/10.1093/cid/cis022.
16. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R. 2013. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255-2265. https://doi.org/10.1056/NEJMoa1207290.
17. Smith T, Philmon CL, Johnson GD, Ward WS, Rivers LL, Williamson SA, Goodman EL. 2014. Antimicrobial stewardship in a community hospital: Attacking the more difficult problems. Hosp Pharm 49:839-846. https://doi.org/10.1310/hpj4909-839.
18. Le Gall JR, Lemeshow S, Saulnier F. 1993. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963. https://doi.org/10.1001/jama.1993.03510240069035.
19. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. 2004. Acute renal failure- definition, outcome measures, animal models, fluid therapy, and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 8:R204 -R212. https://doi.org/10.1186/cc2872.